Bausch + Lomb reported solid Q4 and full-year 2024 earnings ... Invest alongside the model portfolio or simply access the investment bank-grade financial models and research.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report), Evolent Health (EVH – Research Report) and Bausch ...

Appio emphasized three strategic pillars for value creation: enhancing operational assets, unlocking the value of Bausch + Lomb equity, and optimizing the capital structure through debt reduction ...

The change reflects the impact of higher sales, partially offset by increased selling, general and administrative expenses in the Bausch + Lomb segment, as well as the goodwill impairment charges ...

"2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating ...

"2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating cash ...

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.24 per share a year ago.

We apologize, but this video has failed to load. VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live ...

(RTTNews) - Bausch + Lomb Corp. (BLCO), Wednesday announced the financial outlook, expecting revenue of $4.950 billion to $5.050 billion for the fiscal year 2025. Analysts, on average, estimates ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2024 ...

Bausch + Lomb Corp (BLCO) reported stronger-than-expected results for the fourth quarter of 2024, with both earnings per share (EPS) and revenue surpassing analyst forecasts. The company posted an ...